Aigen Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Aigen Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$585K	Buy	+2,390	New	+$518K	0.16%	171
2025 Q3	–	Sell	-4,063	Closed	-$424K	–	790
2025 Q2	$424K	Sell	4,063 -2,671	-40%	-$283K	0.06%	439
2025 Q1	$785K	Buy	6,734 +2,071	+44%	+$236K	0.13%	251
2024 Q4	$395K	Buy	+4,663	New	+$429K	0.07%	403
2024 Q1	–	Sell	-3,866	Closed	-$308K	–	672
2023 Q4	$308K	Buy	+3,866	New	+$258K	0.05%	477
2023 Q1	–	Sell	-3,046	Closed	-$235K	–	617
2022 Q4	$235K	Buy	+3,046	New	+$182K	0.03%	418

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aigen Investment Management's AXSM Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 2,390 shares worth $585K. The stake represents 0.16% of the portfolio and ranks #171 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in AXSM as recently as Q2 2025.

Aigen Investment Management first reported a position in AXSM in Q4 2022 and has held it in 6 quarters since. The position peaked at $785K in Q1 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Aigen Investment Management held 2,390 shares of Axsome Therapeutics worth $585K as of Q2 2026.
Axsome Therapeutics was a new Aigen Investment Management position in Q2 2026.
Axsome Therapeutics made up 0.16% of Aigen Investment Management's portfolio in Q2 2026, its #171 holding.
Aigen Investment Management first reported a position in Axsome Therapeutics in Q4 2022 and has held it in 6 quarters since.
Aigen Investment Management's Axsome Therapeutics position peaked at $785K in Q1 2025.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.